COMMUNIQUÉS West-GlobeNewswire

Rentschler Biopharma announces largest single investment at its headquarters in Germany

24/10/2024 - 07:30

Construction of a new buffer media facility in Laupheim Largest investment in the German site; project duration of approx. three years Continuous modernization, automation, and digitalization of the site LAUPHEIM, [...]

ONWARD® Medical lève avec succès 50 millions d’euros dans le cadre d’une levée de fonds majorée avec le soutien d’Ottobock SE & Co. KGaA

24/10/2024 - 07:30

Ottobock, un leader mondial dans le domaine des prothèses, des orthèses et des exosquelettes, acquiert environ 10% du capital d’ONWARD Medical N.V. concrétisant un partenariat stratégique La couverture des besoins en [...]

ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA

24/10/2024 - 07:30

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Ottobock, a global leader in the fields of prosthetics, orthotics and exoskeleton [...]

Medigene AG reports Financial Results and Business Update for Q3 2024

24/10/2024 - 07:30

Planegg/Martinsried, October 24, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies [...]

Novartis ribociclib (Kisqali®) recognized as Category 1 preferred breast cancer adjuvant treatment by NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)

24/10/2024 - 07:15

Ribociclib (Kisqali) plus aromatase inhibitor (AI) recommended for HR+/HER2- early breast cancer (EBC) node-positive and high-risk node-negative patients, as studied in the NATALEE trial and indicated by the FDA 1 [...]

argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024

24/10/2024 - 07:00

October 24, 2024 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that [...]

PolTREG launches Phase 2 cell therapy trial in children with presymptomatic diabetes

24/10/2024 - 07:00

Treating diabetes patients earlier with PTG-007 could provide functional cure Recruitment will go ahead after European Medicines Agency approval Company has 12 years’ worth of safety and efficacy data for PTG-007 Gdańsk [...]

Pharming Group reports third quarter 2024 financial results and provides business update

24/10/2024 - 07:00

Third quarter 2024 total revenues increased by 12% to US$74.8 million, compared to the third quarter 2023, driven by continued strong RUCONEST® and Joenja® revenue growth RUCONEST® third quarter revenu e increased by 6 [...]

MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium)

24/10/2024 - 01:00

LA JOLLA, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

Jushi Holdings Inc. to Report Third Quarter 2024 Financial Results on November 7, 2024

24/10/2024 - 00:08

BOCA RATON, Florida, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF) , a vertically integrated, multi-state cannabis operator, announced that it expects to [...]

FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent

24/10/2024 - 00:01

MELBOURNE, Australia, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New [...]

Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call

23/10/2024 - 22:50

DALLAS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]

Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024

23/10/2024 - 22:45

LEXINGTON, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to [...]

STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024

23/10/2024 - 22:30

DUBLIN, IRELAND, Oct. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 second quarter financial results at 9: [...]

Clover Health to Report Third Quarter 2024 Financial Results on November 6

23/10/2024 - 22:05

FRANKLIN, Tenn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report third quarter 2024 financial results after market close on [...]

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30

23/10/2024 - 22:05

SILVER SPRING, Md., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a leader in drug-eluting biomatrix products, today announced that Dr. Randy Mills, President and Chief Executive Officer, will [...]

OrthoPediatrics Corp. to Report Third Quarter 2024 Financial Results on November 7, 2024

23/10/2024 - 22:05

WARSAW, Ind., Oct. 23, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]

New Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using Tablo

23/10/2024 - 22:05

Outset Medical features patient experience poster presentations at Kidney Week 2024 Consensus recommendations for use of catheters in home hemodialysis patients published in Kidney Medicine SAN JOSE, Calif., Oct. 23, [...]

WW International, Inc. Schedules Third Quarter 2024 Earnings Conference Call

23/10/2024 - 22:01

NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the third quarter 2024 before market open on Wednesday, November 6 [...]